Johnson M A, Hughes D C, Stevens L M. "Method for the Synthesis of 3-Cyclopropyl-N-propyl-1,2,4-oxadiazol-5-amine" [P]. US Patent, US 9369646 B2, 2020-10-12.
发明人陈志强,黄志刚,刘建华. "A Process for Preparing High-Purity 3-Cyclopropyl-N-propyl-1,2,4-oxadiazol-5-amine" [P]. 中国发明专利, 专利号 CN 117991319 A, 授权公告日 2015-11-07.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2017, 742, 6500-6510.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2025, 2137, (12), 4749-4762.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 3-Cyclopropyl-N-propyl-1,2,4-oxadiazol-5-amine Using HRMS and NMR". Biomed. Chromatogr., 2012, 1763, (12), 2256-2280.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2015, 520, (1), 5358-5383.